361 related articles for article (PubMed ID: 34725309)
1. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
Jia F; Wang G; Xu J; Long J; Deng F; Jiang W
Aging (Albany NY); 2021 Nov; 13(21):23895-23912. PubMed ID: 34725309
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
[TBL] [Abstract][Full Text] [Related]
3. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
Smail SW; Babaei E; Amin K; Abdulahad WH
Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
[TBL] [Abstract][Full Text] [Related]
4. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
Front Immunol; 2021; 12():592727. PubMed ID: 33968010
[TBL] [Abstract][Full Text] [Related]
5. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
[No Abstract] [Full Text] [Related]
7. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the changes of inflammatory cytokine levels in patients with critical coronavirus disease 2019 undergoing invasive mechanical ventilation].
Shan H; Lyu Z; Xiao Y; Li C; Wang J; He L; Chen F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1051-1055. PubMed ID: 33081889
[TBL] [Abstract][Full Text] [Related]
9. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen L; Liu HG; Liu W; Liu J; Liu K; Shang J; Deng Y; Wei S
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):203-208. PubMed ID: 32164089
[No Abstract] [Full Text] [Related]
11. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
Ni M; Tian FB; Xiang DD; Yu B
J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
[TBL] [Abstract][Full Text] [Related]
12. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
[TBL] [Abstract][Full Text] [Related]
13. Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
Bayraktar N; Turan H; Bayraktar M; Ozturk A; Erdoğdu H
J Med Virol; 2022 Jan; 94(1):154-160. PubMed ID: 34427934
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
15. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.
Rutkowska E; Kwiecień I; Żabicka M; Maliborski A; Raniszewska A; Kłos K; Urbańska W; Klajnowicz I; Rzepecki P; Chciałowski A
Viruses; 2021 May; 13(5):. PubMed ID: 34064802
[TBL] [Abstract][Full Text] [Related]
16. Distinct cytokine profiles associated with COVID-19 severity and mortality.
Dorgham K; Quentric P; Gökkaya M; Marot S; Parizot C; Sauce D; Guihot A; Luyt CE; Schmidt M; Mayaux J; Beurton A; Le Guennec L; Demeret S; Ben Salah E; Mathian A; Yssel H; Combadiere B; Combadiere C; Traidl-Hoffmann C; Burrel S; Marcelin AG; Amoura Z; Voiriot G; Neumann AU; Gorochov G
J Allergy Clin Immunol; 2021 Jun; 147(6):2098-2107. PubMed ID: 33894209
[TBL] [Abstract][Full Text] [Related]
17. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
[TBL] [Abstract][Full Text] [Related]
18. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
19. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
Blot M; Bour JB; Quenot JP; Bourredjem A; Nguyen M; Guy J; Monier S; Georges M; Large A; Dargent A; Guilhem A; Mouries-Martin S; Barben J; Bouhemad B; Charles PE; Chavanet P; Binquet C; Piroth L;
J Transl Med; 2020 Dec; 18(1):457. PubMed ID: 33272291
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of IL-8 for the death of severe or critical patients with COVID-19.
Li H; Zhang J; Fang C; Zhao X; Qian B; Sun Y; Zhou Y; Hu J; Huang Y; Ma Q; Hui J
Medicine (Baltimore); 2021 Mar; 100(11):e23656. PubMed ID: 33725924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
